About GF FUND MANAGEMENT CO LTD CHINA SECS INNOVATIVE PHARMA IND ETF
Expense ratio
0.60%
Home page
Inception date
Dec 3, 2020
ISIN
CNE100004DF0
Tightly track the target index, pursue the minimization of tracking deviation and tracking err. The Fund strives to control the absolute value of the daily average tracking deviation between the net value growth rate of the investment portfolio & the performance benchmark is less than 0.2% & the annualized tracking deviation is less than 0.2%.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.82%
Health Technology91.83%
Commercial Services6.97%
Distribution Services0.01%
Electronic Technology0.00%
Process Industries0.00%
Technology Services0.00%
Producer Manufacturing0.00%
Utilities0.00%
Non-Energy Minerals0.00%
Consumer Durables0.00%
Bonds, Cash & Other1.18%
Cash1.18%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history